
Sign up to save your podcasts
Or


Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.
By Modern Optometry5
1515 ratings
Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.

75 Listeners

1,148 Listeners

9,194 Listeners

8,043 Listeners

63 Listeners

80 Listeners

540 Listeners

5 Listeners

18 Listeners

20 Listeners

821 Listeners

21 Listeners

376 Listeners

19 Listeners

18 Listeners